dog |
LD50 |
oral |
> 500mg/kg (500mg/kg) |
|
Drugs in Japan Vol. -, Pg. 767, 1990. |
man |
TDLo |
oral |
571ug/kg (0.571mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE |
Annals of Internal Medicine. Vol. 97, Pg. 454, 1982. |
man |
TDLo |
oral |
64mg/kg/4W-I (64mg/kg) |
GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF ENDOCRINE PANCREAS |
British Journal of Clinical Practice. Vol. 43, Pg. 74, 1989. |
mouse |
LD50 |
intraperitoneal |
270mg/kg (270mg/kg) |
|
"Pharmacology of Antihypertensive Drugs," Scriabine, A., ed., New York, Raven Press, 1980Vol. -, Pg. 295, 1980. |
mouse |
LD50 |
intravenous |
47100ug/kg (47.1mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985. |
mouse |
LD50 |
oral |
3800mg/kg (3800mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
BEHAVIORAL: ANTIPSYCHOTIC |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981. |
mouse |
LD50 |
subcutaneous |
> 1gm/kg (1000mg/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981. |
rat |
LD50 |
intraperitoneal |
322mg/kg (322mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985. |
rat |
LD50 |
intravenous |
59200ug/kg (59.2mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985. |
rat |
LD50 |
oral |
5300mg/kg (5300mg/kg) |
|
"Pharmacology of Antihypertensive Drugs," Scriabine, A., ed., New York, Raven Press, 1980Vol. -, Pg. 295, 1980. |
rat |
LD50 |
subcutaneous |
> 1gm/kg (1000mg/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981. |